Graft-versus-Host Disease as Adoptive Immunotherapy in Patients with Advanced Hematologic Neoplasms
Keith M. Sullivan(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), E. Donnall Thomas(AbbVie (United States)), Jack W. Singer(NorthShore University HealthSystem), M Banaji, Rainer Storb(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Jean E. Sanders(Carolinas Medical Center), Alexander Fefer(University of Washington), Lloyd D. Fisher(University of Washington), C. Dean Buckner(University of Washington), Paul S. Martin(University of Washington), Robert P. Witherspoon(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), John A. Hansen(University of Washington), F R Appelbaum(City Of Hope National Medical Center), Paul L. Weiden(Seattle University)
Cited by 354
Related Papers
Chronic graft-versus-host syndrome in man
|The American Journal of Medicine|1980|2.4k
HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
|Biology of Blood and Marrow Transplantation|2008|1.9k
Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor
|New England Journal of Medicine|1995|1.8k
Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia
|New England Journal of Medicine|1986|1.5k